Clinical Screening
Cross-source consensus on Clinical Screening from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Comparisons
Evidence quality
Highlighted claims
- The findings support systematic screening for insulin omission when people with type 1 diabetes have altered CGM metrics or elevated HbA1c. — Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study
- Screening should include men and people with normal or high BMI rather than focusing only on women or low BMI. — Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study
- The study highlights that eating disorders and insulin omission occur beyond the stereotype of young lean women. — Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study
- Diabetes care should integrate somatic and psychological expertise because shame and guilt may make disclosure difficult. — Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study
- Automated insulin delivery was presented as a possible future perspective, not a proven intervention for people with eating disorders or insulin omission. — Association of eating disorders and/or insulin omission with impaired glycaemic control in persons living with type 1 diabetes: cross-sectional analysis of the French SFDT1 study